The purpose of the company is the development and distribution of pharmaceutical active ingredients and technologies for their development, as well as technologies for diagnostics and biomedical research. The company may acquire, hold, manage, exploit, and transfer real estate and intangible assets, both domestically and internationally, and may establish branches and subsidiaries abroad. The company may participate in group financing, particularly by granting loans to its direct or indirect shareholders or other group companies or providing guarantees or other securities of any kind for their liabilities to third parties, even if such loans or securities are in the exclusive interest of its direct or indirect shareholders or other group companies or are granted free of charge. Furthermore, the company may engage in any other business that appears suitable to promote the purpose of the company or is related thereto.